DCF — NORTHERN NEVADA MEDICAL CENTER
Enterprise Value: $135.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$135.4M
Enterprise Value
$36.1M
PV of Cash Flows
$99.3M
PV of Terminal Value
$160.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $155.3M | $17.1M | 11.0% | $7.2M | $6.5M |
| Year 2 | $160.0M | $19.2M | 12.0% | $8.6M | $7.1M |
| Year 3 | $164.8M | $21.4M | 13.0% | $10.1M | $7.6M |
| Year 4 | $169.7M | $22.9M | 13.0% | $11.0M | $7.5M |
| Year 5 | $174.8M | $24.0M | 14.0% | $11.7M | $7.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $135.4M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$150.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1049024266655058
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5